As drug development grows increasingly complex, pharma and biotech teams are seeking partners with the scientific depth and ...

Vetter, a globally leading CDMO, announces the retirement of its Managing Director Thomas Otto after more than 35 years at the company. He will step down at the end of 2025.

Medra, a company developing a platform for Physical AI Scientists, has announced a $52 million Series A financing led by ...

Charles River Laboratories International Inc. has announced the second cohort of its Cell & Gene Therapy Incubator Program (CIP).

Jai Murthy of Actylis shares insight on overcoming supply chain fragility, buffer prep solutions, and approaches to customization.

Cytiva, a life sciences company, and Fida Biosystems, a Danish company specializing in molecular analysis, have joined forces ...

The Wellcome Sanger Institute has selected the Sapio Informatics Platform as its central LIMS to underpin the Institute’s lab ...

Advarra has added several new eClinical technologies to its network of partner applications within its Study Collaboration ...

Tjoapack is expanding its operational footprint in the U.S. with a new 170,000-square-foot facility adjacent to its existing ...

Formycon will develop, register, manufacture, and supply the product, while Zydus will be responsible for commercialization.

Expression Therapeutics Inc., a clinical-stage biopharmaceutical company developing next-generation cellular therapies, has appointed David F. Townson, Ph.D., as Chief Executive Officer, effective ...

Bora Pharmaceuticals Co. Ltd. and Corealis Pharma Inc. have entered into a strategic alliance to provide end-to-end services ...